Apellis Pharmaceuticals Announces Appointment of Dr. Robert Kim as Chief Medical Officer
In All, PortfolioLOUISVILLE, Ky., Aug. 8, 2016 – Apellis Pharmaceuticals, Inc., a clinical stage complement immunotherapy company, announced today the expansion of its executive team with the addition of Dr. Robert Kim as its Chief Medical Officer. Dr. Kim will help the company optimize its drug development strategy as its clinical…